COVID 19 Vaccine Programs Update

Milestones :: Perspectives :: Research


COVID 19 Vaccine Programs Update

Moderna Completes Enrollment of Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273)
October 22, 2020
:: Moderna to make statement at today’s FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting
:: Moderna thanks PPD, its CRO partner, for the successful execution of COVE Study enrollment



Canada’s Prime Minister, Justin Trudeau, Announced Today Precision NanoSystems Will Receive $18.2 Million from the Government of Canada to Develop an RNA Vaccine for COVID-19
:: PNI will use the investment to advance a cost-effective Made-in-Canada COVID-19 vaccine
:: PNI offers expertise in self-amplifying mRNA vectors, lipid-based drug delivery systems and nanomedicine manufacturing
:: PNI will contribute to Canada’s ability to secure an effective COVID-19 vaccine and build technologies towards enabling rapid response against future pandemics
Oct 23, 2020, 14:00 ET